
CAS 1258595-14-0
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
LHC-165
CAS:<p>LHC-165 is a biodegradable polymer drug that targets the tumor microenvironment. LHC-165 has been shown to induce myeloid-derived suppressor cells (MDSCs) and inhibit TGF-β signaling. MDSCs are immunosuppressive cells that have been implicated in tumor progression and resistance to therapy, as well as in postoperative recurrence of cancer. The mechanism of action of LHC-165 is mediated by toll-like receptor 4 (TLR4) activation. This leads to an intratumoral accumulation of MDSCs and an intraoperative reduction in their number. In addition, LHC-165 has been shown to be effective for the treatment of colorectal cancer when used with resection or radiation therapy.</p>Formula:C29H32F2N3O7PPurity:Min. 95%Molecular weight:603.55 g/molLHC-165
CAS:<p>LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.</p>Formula:C29H32F2N3O7PPurity:98%Color and Shape:SolidMolecular weight:603.55

